These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 33768618)

  • 1. The effect of trehalose, antioxidants, and acetate buffer concentration on oxytocin stability.
    Ghasemisarabbadieh M; Gizurarson S; Sveinbjörnsson BR
    J Pept Sci; 2021 Jul; 27(7):e3324. PubMed ID: 33768618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new strategy to stabilize oxytocin in aqueous solutions: I. The effects of divalent metal ions and citrate buffer.
    Avanti C; Amorij JP; Setyaningsih D; Hawe A; Jiskoot W; Visser J; Kedrov A; Driessen AJ; Hinrichs WL; Frijlink HW
    AAPS J; 2011 Jun; 13(2):284-90. PubMed ID: 21448747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspartate buffer and divalent metal ions affect oxytocin in aqueous solution and protect it from degradation.
    Avanti C; Oktaviani NA; Hinrichs WL; Frijlink HW; Mulder FA
    Int J Pharm; 2013 Feb; 444(1-2):139-45. PubMed ID: 23376504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of amide- and imide-linked degradation products between the peptide drug oxytocin and citrate in citrate-buffered formulations.
    Poole RA; Kasper PT; Jiskoot W
    J Pharm Sci; 2011 Jul; 100(7):3018-22. PubMed ID: 21547912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of D-(+)-glucosamine, N-acetyl-D-glucosamine and tetraethylene glycol on the stability of oxytocin in aqueous solution.
    Ghasemisarabbadieh M; Sigurdsson SJ; Dong FVN; Gizurarson S; Sveinbjörnsson BR
    Pharmazie; 2021 Oct; 76(10):480-483. PubMed ID: 34620274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 18-Crown-6 on Oxytocin Stability in Aqueous Buffer Solutions.
    Ghasemisarabbadieh M; Gizurarson S; Sveinbjornsson BR
    ACS Omega; 2021 Mar; 6(8):5805-5811. PubMed ID: 33681619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid technique to evaluate the oxidative stability of a model drug.
    Felton LA; Yang J; Shah K; Omidian H; Rocca JG
    Drug Dev Ind Pharm; 2007 Jun; 33(6):683-9. PubMed ID: 17613032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trehalose limits BSA aggregation in spray-dried formulations at high temperatures: implications in preparing polymer implants for long-term protein delivery.
    Rajagopal K; Wood J; Tran B; Patapoff TW; Nivaggioli T
    J Pharm Sci; 2013 Aug; 102(8):2655-66. PubMed ID: 23754501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Aggregation in Frozen Trehalose Formulations: Effects of Composition, Cooling Rate, and Storage Temperature.
    Connolly BD; Le L; Patapoff TW; Cromwell MEM; Moore JMR; Lam P
    J Pharm Sci; 2015 Dec; 104(12):4170-4184. PubMed ID: 26398200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of buffer and antioxidant on stability of a mercaptopurine suspension.
    Aliabadi HM; Romanick M; Desai S; Lavasanifar A
    Am J Health Syst Pharm; 2008 Mar; 65(5):441-7. PubMed ID: 18281736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral Inhalation.
    Fabio K; Curley K; Guarneri J; Adamo B; Laurenzi B; Grant M; Offord R; Kraft K; Leone-Bay A
    AAPS PharmSciTech; 2015 Dec; 16(6):1299-306. PubMed ID: 25776985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology.
    Teeranachaideekul V; Junyaprasert VB; Souto EB; Müller RH
    Int J Pharm; 2008 Apr; 354(1-2):227-34. PubMed ID: 18242898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new strategy to stabilize oxytocin in aqueous solutions: II. Suppression of cysteine-mediated intermolecular reactions by a combination of divalent metal ions and citrate.
    Avanti C; Permentier HP; Dam Av; Poole R; Jiskoot W; Frijlink HW; Hinrichs WL
    Mol Pharm; 2012 Mar; 9(3):554-62. PubMed ID: 22257021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermal and solution stability of lysozyme in the presence of sucrose, glucose, and trehalose.
    James S; McManus JJ
    J Phys Chem B; 2012 Aug; 116(34):10182-8. PubMed ID: 22909409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of Octastatin, a somatostatin analog cyclic octapeptide, in aqueous solution.
    Jang SW; Woo BH; Lee JT; Moon SC; Lee KC; DeLuca PP
    Pharm Dev Technol; 1997 Nov; 2(4):409-14. PubMed ID: 9552470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the myotoxicity of pharmaceutical buffers using an in vitro muscle model: effect of pH, capacity, tonicity, and buffer type.
    Napaporn J; Thomas M; Svetic KA; Shahrokh Z; Brazeau GA
    Pharm Dev Technol; 2000; 5(1):123-30. PubMed ID: 10669926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antioxidants and silicates on peroxides in povidone.
    Narang AS; Rao VM; Desai DS
    J Pharm Sci; 2012 Jan; 101(1):127-39. PubMed ID: 22109686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability Enhancing N-Terminal PEGylation of Oxytocin Exploiting Different Polymer Architectures and Conjugation Approaches.
    Collins J; Kempe K; Wilson P; Blindauer CA; McIntosh MP; Davis TP; Whittaker MR; Haddleton DM
    Biomacromolecules; 2016 Aug; 17(8):2755-66. PubMed ID: 27419537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a thermostable oxytocin microneedle patch.
    Gomaa Y; Kolluru C; Milewski M; Lee D; Zhang J; Saklatvala R; Prausnitz MR
    J Control Release; 2021 Sep; 337():81-89. PubMed ID: 34265331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of different co-antioxidants on the photochemical- and functional-stability of epigallocatechin-3-gallate in topical creams exposed to simulated sunlight.
    Scalia S; Marchetti N; Bianchi A
    Molecules; 2013 Jan; 18(1):574-87. PubMed ID: 23292326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.